(From left in photo) Lunit Insight CXR, Lunit Insight MMG / Photo = Lunit
Lunit (CEO Beom-seok Seo), a medical artificial intelligence (AI) company, is working with TeleDiag, the largest teleradiology collaborative network in France, and the Portuguese non-profit organization Liga Portuguesa Contra de Cancer. It announced on the 18th that it signed an AI solution supply contract with the Central Center ‘LPCC’ and began targeting the European medical market.
First of all, Lunit recently signed a contract with Telediac to supply ‘Lunit Insight CXR’, an AI chest X-ray image analysis solution. Telediac was founded by French doctors in 2008 to solve medical inequalities in vulnerable groups through remote digital technology and to facilitate faster diagnosis in emergency situations. Telediac currently has more than 600 radiologists who diagnose more than 600,000 patients each year, and provides remote diagnosis services to more than 300 partner institutions.
In particular, in the process of introducing this AI solution, Telediac is said to have chosen the Lunit product after comparing chest X-ray image analysis solutions from three global companies, including Lunit Insight CXR, proving once again the technological excellence of Lunit. In addition, Lunit recently signed a contract with the LPCC Central Center in Portugal to supply ‘Lunit Insight MMG’, an AI mammography image analysis solution.
Founded in 1941, LPCC is a non-profit organization that provides cancer prevention campaigns, early diagnosis programs, and support services for patients and families, contributing to the Portuguese government’s cancer response program. LPCC currently operates five branches in Portugal, and the Central Center of LPCC, which signed a contract with Lunit this time, operates a national breast screening program in Coimbra, the largest city in the central region.
Prior to this contract, the LPCC Central Center conducted a thorough internal verification of the Lunit AI solution using its own patient data and then signed a final contract with Lunit. We plan to run a breast cancer screening program.
Seo Beom-seok, CEO of Lunit, said, “This supply contract with Western European countries re-proves our superior technology and product quality compared to our competitors.” “It will play an important role in becoming a leading company in the medical AI field.”
#Lunit #supplies #video #analytics #solution #France #Portugal
